Francesca Romana Santoni de Sio

Francesca Romana Santoni de Sio

Auto-generated profile, based on publicly available information

Francesca Romana Santoni de Sio

School of Life Sciences, École Polytechnique Fédérale De Lausanne, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2005 in Blood
Verified
Journal Article
Open access
PDF file
MPMichele De Palma
Michele De Palma
EMEugenio Montini
Eugenio Montini
FSFrancesca R. Santoni de Sio
Francesca R. Santoni de Sio
FBFabrizio Benedicenti
Fabrizio Benedicenti
AGAlessandra Gentile
Alessandra Gentile
LNLuigi Naldini
Luigi Naldini
Recent reports have indicated that human immunodeficiency virus (HIV) and murine leukemia virus (MLV) vectors preferentially integrate into active genes. Here, we used a novel approach based on genetic trapping to rapidly score several thousand integration sites and found that MLV vectors trapped cellular promoters more efficiently than HIV vectors. Remarkably, 1 in 5 MLV integrations trapped an active promoter in different cell lines and primary hematopoietic cells. Such frequency was even higher in growth-stimulated lymphocytes. We show that the different behavior of MLV and HIV vectors was dependent on a different integration pattern within transcribed genes. Whereas MLV-based traps showed a strong bias for promoter-proximal integration leading to efficient reporter expression, HIV-based traps integrated throughout transcriptional units and were limited for expression by the distance from the promoter and the reading frame of the targeted gene. Our results indicate a strong propensity of MLV to establish transcriptional interactions with cellular promoters, a behavior that may have evolved to enhance proviral expression and may increase the insertional mutagenesis risk. Promoter trapping efficiency provides a convenient readout to assess transcriptional interactions between the vector and its flanking genes at the integration site and to compare integration site selection among different cell types and in different growth conditions.

8 September 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
DCDaniela Cesana
Daniela Cesana
FSFrancesca R. Santoni de Sio
Francesca R. Santoni de Sio
LRLaura Rudilosso
Laura Rudilosso
PGPierangela Gallina
Pierangela Gallina
ACAndrea Calabria
Andrea Calabria
EMEugenio Montini
Eugenio Montini
HIV-1 insertions targeting BACH2 or MLK2 are enriched and persist for decades in hematopoietic cells from patients under combination antiretroviral therapy. However, it is unclear how these insertions provide such selective advantage to infected cell clones. Here, we show that in 30/87 (34%) patients under combination antiretroviral therapy, BACH2, and STAT5B are activated by insertions triggering the formation of mRNAs that contain viral sequences fused by splicing to their first protein-coding exon. These chimeric mRNAs, predicted to express full-length proteins, are enriched in T regulatory and T central memory cells, but not in other T lymphocyte subsets or monocytes. Overexpression of BACH2 or STAT5B in primary T regulatory cells increases their proliferation and survival without compromising their function. Hence, we provide evidence that HIV-1-mediated insertional activation of BACH2 and STAT5B favor the persistence of a viral reservoir in T regulatory cells in patients under combination antiretroviral therapy.

8 June 2012 in Hepatology
Verified
Journal Article
Open access
PDF file
KBKarolina Bojkowska
Karolina Bojkowska
FAFabio Aloisio
Fabio Aloisio
MCMarco Cassano
Marco Cassano
AKAdamandia Kapopoulou
Adamandia Kapopoulou
FSFrancesca Santoni de Sio
Francesca Santoni de Sio
DTDidier Trono
Didier Trono
The liver is characterized by sexually dimorphic gene expression translating into sex-specific differences in lipid, drug, steroid hormone, and xenobiotic metabolism, with distinct responses of males and females to environmental challenges. Here, we investigated the role of the Krüppel-associated box (KRAB)-associated protein 1 (KAP1) epigenetic regulator in this process. Liver-specific KAP1 knockout (KO) led to strikingly sexually dimorphic phenotypic disturbances, including male-predominant steatosis and hepatic tumors with up-regulation of protein kinase B and extracellular signal-related kinases 1/2 mitogen-activated protein kinase signaling. This correlated with the sex-specific transcriptional dysregulation of a wide range of metabolic genes, notably those involved in retinol and sex hormone processing as well as in detoxification. Furthermore, chromatin immunoprecipitation followed by deep sequencing indicated that a number of dysregulated genes are direct targets of the KRAB/KAP1 repression system. Those genes include sexually dimorphic cytochrome P 450 Cyp 2d9 , glutathione S -transferase π, Cyp2a , Cyp2b , and Cyp3a gene clusters. Additionally, we identified a male-restricted KAP1-binding site in the fat-specific protein 27 gene, correlating with its male-predominant up-regulation upon Kap1 deletion, suggesting that the latter might be an important trigger in the development of male-specific hepatosteatosis and secondary tumorigenesis. Conclusion: This work reveals KRAB/KAP1-mediated transcriptional regulation as a central event in metabolic control hormones, drugs, and xenobiotics in the liver and further links disturbances in these processes with hepatic carcinogenesis. (Hepatology 2012)

7 August 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
FSFrancesca R. Santoni de Sio
Francesca R. Santoni de Sio
IBIsabelle Barde
Isabelle Barde
SOSandra Offner
Sandra Offner
AKAdamandia Kapopoulou
Adamandia Kapopoulou
ACAndrea Corsinotti
Andrea Corsinotti
DTDidier Trono
Didier Trono
Chromatin remodeling at specific genomic loci controls lymphoid differentiation. Here, we investigated the role played in this process by Kruppel‐associated box (KRAB)‐associated protein 1 (KAP1), the universal cofactor of KRAB‐zinc finger proteins (ZFPs), a tetrapod‐restricted family of transcriptional repressors. T‐cell‐specific Kap1 ‐deleted mice displayed a significant expansion of immature thymocytes, imbalances in CD4 + /CD8 + cell ratios, and altered responses to TCR and TGFβ stimulation when compared to littermate KAP1 control mice. Transcriptome and chromatin studies revealed that KAP1 binds T‐cell‐specific cis ‐acting regulatory elements marked by the H3K9me3 repressive mark and enriched in Ikaros/NuRD complexes. Also, KAP1 directly controls the expression of several genes involved in TCR and cytokine signaling. Among these, regulation of FoxO1 seems to play a major role in this system. Likely responsible for tethering KAP1 to at least part of its genomic targets, a small number of KRAB‐ZFPs are selectively expressed in T‐lymphoid cells. These results reveal the so far unsuspected yet important role of KAP1‐mediated epigenetic regulation in T‐lymphocyte differentiation and activation.—Santoni de Sio, F. R., Barde, I., Offner, S., Kapopoulou, A., Corsinotti, A., Bojkowska, K., Genolet, R., Thomas, J. H., Luescher, I. F., Pinschewer, D., Harris, N., Trono, D. KAP1 regulates gene networks controlling T‐cell development and responsiveness. FASEB J. 26, 4561–4575 (2012). www.fasebj.org

17 May 2012 in Blood
Verified
Journal Article
Closed access
PDF file
FSFrancesca R. Santoni de Sio
Francesca R. Santoni de Sio
JMJoanna Massacand
Joanna Massacand
IBIsabelle Barde
Isabelle Barde
SOSandra Offner
Sandra Offner
ACAndrea Corsinotti
Andrea Corsinotti
DTDidier Trono
Didier Trono
Chromatin remodeling is fundamental for B-cell differentiation. In the present study, we explored the role of KAP1, the cofactor of KRAB-ZFP transcriptional repressors, in this process. B-lymphoid–specific Kap1-KO mice displayed reduced numbers of mature B cells, lower steady-state levels of Abs, and accelerated rates of decay of neutralizing Abs after viral immunization. Transcriptome analyses of Kap1-deleted B splenocytes revealed an up-regulation of PTEN, the enzymatic counteractor of PIK3 signaling, and of genes encoding DNA-damage response factors, cell-cycle regulators, and chemokine receptors. ChIP/seq studies established that KAP1 bound at or close to several of these genes and controlled chromatin status at their promoters. Genome wide, KAP1 binding sites lacked active B cell–specific enhancers and were enriched in repressive histone marks, further supporting a role for this molecule in gene silencing in vivo. Likely responsible for tethering KAP1 to at least some of these targets, a discrete subset of KRAB-ZFPs is enriched in B lymphocytes. Our results therefore reveal the role of KRAB/KAP1–mediated epigenetic regulation in B-cell development and homeostasis.

1 November 2002 in Molecular Therapy
Verified
Journal Article
Open access
LAL Ailles
L Ailles
MSM Schmidt
M Schmidt
FSF Santonidesio
F Santonidesio
HGH Glimm
H Glimm
SCS Cavalieri
S Cavalieri
LNL Naldini
L Naldini
A major challenge in gene therapy is to achieve efficient transduction of hematopoietic stem cells (HSC). It has previously been shown that lentiviral vectors (LV) transduce efficiently human cord blood-derived NOD/SCID mouse repopulating cells (SRC). Here we studied the effect of cytokines during the short ex vivo incubation with vector. Although SRC transduction was efficient without stimulation, the presence of cytokines significantly improved it. The treatment did not affect the engraftment level or the SRC frequency, but seemed to enhance SRC susceptibility to LV. SRC transduced in both conditions repopulated primary and secondary recipients, maintaining stable multi-lineage transgene expression. Using linear amplification-mediated PCR, we then analyzed vector integration in the bone marrow and CFC of the engrafted mice to monitor the clonal activity of the transduced SRC in vivo. We showed polyclonal engraftment, multi-lineage differentiation, and propagation to secondary recipients of individual SRC. We observed multiple integrations in most clones. These results provide the first formal demonstration that primitive human HSC with self-renewal and multi-lineage repopulation capacities were transduced by LV. Our findings are relevant for the design of clinical protocols that exploit this system to reach significant engraftment by genetically modified HSC in the absence of in vivo selection or strong conditioning regimens.